Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

The Peierls Foundation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 6
Rounds per year 0.26
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Therapeutics
  • Genetics
  • Medical
Summary

The Peierls Foundation appeared to be the Corporate Investor, which was created in 1988. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the New York.

The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. This The Peierls Foundation works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the The Peierls Foundation, startups are often financed by Boulder Ventures, Atlas Venture, Remeditex Ventures. The meaningful sponsors for the fund in investment in the same round are Boulder Ventures, PBM Capital Group, Longwood Founders Fund. In the next rounds fund is usually obtained by Boulder Ventures, Remeditex Ventures, Fuse Capital.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight ArcherDX, BiOptix Diagnostics, BaroFold. Among the most popular fund investment industries, there are Genetics, Communities.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Peierls Foundation:
Typical Co-investors
The Peierls Foundation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Peierls Foundation:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Axis Direct India, Maharashtra, Mumbai
Beijing Tian Rong Capital Management Beijing, Beijing, China
CHL Medical Partners Connecticut, Stamford, United States
Compaq California, Palo Alto, United States
DSM Heerlen, Limburg, The Netherlands
EMPRENDETUR Community of Madrid, Madrid, Spain
Huaman Chuangmeng China, Ningbo, Zhejiang
Loyall Capital Partners Brazil, São Paulo, Sao Paulo
Malabar Investment Advisors New York, New York, United States
Oxer Kapital AS Norway, South Carolina, United States
Project Flying Elephant Berlin, Berlin, Germany
Rowny Capital District of Columbia, United States, Washington
State Bank of India India, Maharashtra, Mumbai
Symbiotics Group Geneva, Geneve, Switzerland
Synapse Capital California, Fountain Valley, United States
Y.Z. Capital China, Guangdong Province, Zhenjiang
zenrock Lafayette, Louisiana, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ArcherDX

Biopharma
Biotechnology
Genetics
Life Science
$60M15 May 2019 Boulder, Colorado, United States

ArcherDX

Biopharma
Biotechnology
Genetics
Life Science
$35M20 Mar 2018 Boulder, Colorado, United States

BiOptix Diagnostics

Life Science
Medical Device
$9M18 Oct 2010 Boulder, Colorado, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$4M03 Jun 2009 Boulder, Colorado, United States

Quantia

Communities
Health Care
Medical
Social Media
$5M17 Sep 2008 Massachusetts, United States

Biotechnology
Genetics
Medical
Therapeutics
$18M12 Jun 2007 Westminster, Colorado, United States

BaroFold

Biopharma
Biotechnology
Therapeutics
$12M29 May 2007 Aurora, Colorado, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Peierls Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 16M
Rounds per year 0.26
Peak activity year 2007
Lead investments 0
Follow on index 0.33
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ArcherDX

Biopharma
Biotechnology
Genetics
Life Science
$60M15 May 2019 Boulder, Colorado, United States

ArcherDX

Biopharma
Biotechnology
Genetics
Life Science
$35M20 Mar 2018 Boulder, Colorado, United States

BiOptix Diagnostics

Life Science
Medical Device
$9M18 Oct 2010 Boulder, Colorado, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$4M03 Jun 2009 Boulder, Colorado, United States

Quantia

Communities
Health Care
Medical
Social Media
$5M17 Sep 2008 Massachusetts, United States

Biotechnology
Genetics
Medical
Therapeutics
$18M12 Jun 2007 Westminster, Colorado, United States

BaroFold

Biopharma
Biotechnology
Therapeutics
$12M29 May 2007 Aurora, Colorado, United States
Crunchbase icon

Content report

The following text will be sent to our editors: